Professors

George W. Rutherford, MD

University of California San Francisco

Professor of Epidemiology, Preventive Medicine, Pediatrics and History

San Francisco, CA

Head, Division of Infectious Disease and Global Epidemiology
Department of Epidemiology and Biostatistics
University of California San Francisco
San Francisco, CA

Michael S. Saag, MD

University of Alabama at Birmingham

Professor of Medicine, Emeritus

Birmingham, AL

Steven A. Safren, PhD, ABPP

University of Miami

Professor of Psychology and Cooper Fellow

Miami, FL

Sudipa Sarkar, MD

The Johns Hopkins University

Assistant Professor

Baltimore, MD

Paul E. Sax, MD

Brigham and Women’s Hospital

Harvard Medical School

Boston, MA

Brigham and Women’s Hospital
Harvard Medical School
Boston, MA

Kim Scarsi, PharmD

University of Nebraska Medical Center

Professor

Omaha, NE

Morris Schambelan, MD

University of California San Francisco

Professor of Medicine

San Francisco, CA

Robert T. Schooley, MD

University of California San Diego

Professor of Medicine; Co-Director, Center for Innovative Phage Applications and Therapeutics

La Jolla, CA

Dr Schooley is a Distinguished Professor of Medicine in the Division of Infectious Diseases and Global Public Health at the University of California San Diego. He completed medical school, an internal medicine residency at Johns Hopkins, and infectious disease fellowships at the National Institutes of Health (NIH) and Massachusetts General Hospital. He joined the faculty of Harvard Medical School in 1981. His longer-term research efforts are directed at the pathogenesis and therapy of RNA virus infections. He has been heavily involved in the development of antiviral chemotherapy directed at HIV, HCV, and the herpesgroup viruses, as well as in research, teaching, and infrastructure building efforts in sub-Saharan Africa. Following his successful treatment of a multidrug resistant A. baumannii infection in a fellow faculty member at University of California San Diego, he has become interested in the use of viruses as therapeutic agents – namely, the use of bacteriophages to treat multidrug resistant bacterial infections. He currently serves as Co-Director of University of California San Diego’s phage research center (the Center for Innovative Phage Applications and Therapeutics, IPATH).

(Updated July 18, 2024)

Hyman Scott, MD, MPH

University of California San Francisco

Assistant Clinical Professor, School of Medicine

San Francisco, CA

Eileen Scully, MD, PhD

The Johns Hopkins University

Assistant Professor of Medicine

Baltimore, MD